Skip to main content

The biotech start-up company Allcyte focuses on functional drug testing in primary human material. With the so-called “Pharmacoscopy” high-content imaging platform, Allcyte (now Exscientia) supports pre-clinical drug development and clinical decision making services by helping physicians find the right drug for the right patients, and pharmaceutical companies identify the most promising indications for their drugs and drug candidates.

In 2021, Allcyte was acquired by the global pharma tech company Exscientia.